These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
562 related articles for article (PubMed ID: 32905518)
1. The m6A readers Anita R; Paramasivam A; Priyadharsini JV; Chitra S Am J Cancer Res; 2020; 10(8):2546-2554. PubMed ID: 32905518 [TBL] [Abstract][Full Text] [Related]
2. N6-methyladenosine-related Genomic Targets are Altered in Breast Cancer Tissue and Associated with Poor Survival. Liu L; Liu X; Dong Z; Li J; Yu Y; Chen X; Ren F; Cui G; Sun R J Cancer; 2019; 10(22):5447-5459. PubMed ID: 31632489 [No Abstract] [Full Text] [Related]
3. Expression profiles and prognostic significance of RNA N6-methyladenosine-related genes in patients with hepatocellular carcinoma: evidence from independent datasets. Zhou Y; Yin Z; Hou B; Yu M; Chen R; Jin H; Jian Z Cancer Manag Res; 2019; 11():3921-3931. PubMed ID: 31118805 [No Abstract] [Full Text] [Related]
4. Aberrations of m6A regulators are associated with tumorigenesis and metastasis in head and neck squamous cell carcinoma. Arumugam P; George R; Jayaseelan VP Arch Oral Biol; 2021 Feb; 122():105030. PubMed ID: 33383437 [TBL] [Abstract][Full Text] [Related]
5. YTHDF1 amplification is correlated with worse outcome and lower immune cell infiltrations in breast cancer. Li C; Zhang C; Zhang G; Chen B; Li X; Li K; Ren C; Wen L; Liao N Cancer Biomark; 2022; 35(2):127-142. PubMed ID: 35342079 [TBL] [Abstract][Full Text] [Related]
6. The potential role of RNA N6-methyladenosine in primary Sjögren's syndrome. Xiao Q; Wu X; Deng C; Zhao L; Peng L; Zhou J; Zhang W; Zhao Y; Fei Y Front Med (Lausanne); 2022; 9():959388. PubMed ID: 36465909 [TBL] [Abstract][Full Text] [Related]
7. Genomic and transcriptomic alterations in m6A regulatory genes are associated with tumorigenesis and poor prognosis in head and neck squamous cell carcinoma. Paramasivam A; George R; Priyadharsini JV Am J Cancer Res; 2021; 11(7):3688-3697. PubMed ID: 34354868 [TBL] [Abstract][Full Text] [Related]
8. YTHDF1 promotes breast cancer progression by facilitating FOXM1 translation in an m6A-dependent manner. Chen H; Yu Y; Yang M; Huang H; Ma S; Hu J; Xi Z; Guo H; Yao G; Yang L; Huang X; Zhang F; Tan G; Wu H; Zheng W; Li L Cell Biosci; 2022 Feb; 12(1):19. PubMed ID: 35197112 [TBL] [Abstract][Full Text] [Related]
9. Multiomics profile and prognostic gene signature of m6A regulators in uterine corpus endometrial carcinoma. Wang Y; Ren F; Song Z; Wang X; Ma X J Cancer; 2020; 11(21):6390-6401. PubMed ID: 33033522 [TBL] [Abstract][Full Text] [Related]
10. Comprehensive Analysis of Expression Regulation for RNA m6A Regulators With Clinical Significance in Human Cancers. Liu X; Wang P; Teng X; Zhang Z; Song S Front Oncol; 2021; 11():624395. PubMed ID: 33718187 [TBL] [Abstract][Full Text] [Related]
11. Dysregulated m6A-Related Regulators Are Associated With Tumor Metastasis and Poor Prognosis in Osteosarcoma. Li J; Rao B; Yang J; Liu L; Huang M; Liu X; Cui G; Li C; Han Q; Yang H; Cui X; Sun R Front Oncol; 2020; 10():769. PubMed ID: 32582536 [No Abstract] [Full Text] [Related]
12. The comprehensive expression and functional analysis of m6A modification "readers" in hepatocellular carcinoma. Qin S; Liu G; Jin H; Chen X; He J; Xiao J; Qin Y; Mao Y; Zhao L Aging (Albany NY); 2022 Aug; 14(15):6269-6298. PubMed ID: 35963644 [TBL] [Abstract][Full Text] [Related]
13. m6A Regulators Is Differently Expressed and Correlated With Immune Response of Esophageal Cancer. Zhao H; Xu Y; Xie Y; Zhang L; Gao M; Li S; Wang F Front Cell Dev Biol; 2021; 9():650023. PubMed ID: 33748145 [TBL] [Abstract][Full Text] [Related]
14. Construction and Validation of an m6A RNA Methylation Regulators-Based Prognostic Signature for Esophageal Cancer. Xu LC; Pan JX; Pan HD Cancer Manag Res; 2020; 12():5385-5394. PubMed ID: 32753956 [TBL] [Abstract][Full Text] [Related]
15. The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation. Liu T; Wei Q; Jin J; Luo Q; Liu Y; Yang Y; Cheng C; Li L; Pi J; Si Y; Xiao H; Li L; Rao S; Wang F; Yu J; Yu J; Zou D; Yi P Nucleic Acids Res; 2020 Apr; 48(7):3816-3831. PubMed ID: 31996915 [TBL] [Abstract][Full Text] [Related]
16. Comprehensive Analysis of N6-Methyladenosine (m6A) Writers, Erasers, and Readers in Cervical Cancer. Condic M; Ralser DJ; Klümper N; Ellinger J; Qureischi M; Egger EK; Kristiansen G; Mustea A; Thiesler T Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806168 [TBL] [Abstract][Full Text] [Related]
17. Association of N6-methyladenosine readers' genes variation and expression level with pulmonary tuberculosis. Li HM; Tang F; Wang LJ; Huang Q; Pan HF; Zhang TP Front Public Health; 2022; 10():925303. PubMed ID: 36072379 [TBL] [Abstract][Full Text] [Related]
18. ELK1-mediated YTHDF1 drives prostate cancer progression by facilitating the translation of Polo-like kinase 1 in an m6A dependent manner. Li P; Shi Y; Gao D; Xu H; Zou Y; Wang Z; Li W Int J Biol Sci; 2022; 18(16):6145-6162. PubMed ID: 36439881 [No Abstract] [Full Text] [Related]
19. Reduced m6A modification predicts malignant phenotypes and augmented Wnt/PI3K-Akt signaling in gastric cancer. Zhang C; Zhang M; Ge S; Huang W; Lin X; Gao J; Gong J; Shen L Cancer Med; 2019 Aug; 8(10):4766-4781. PubMed ID: 31243897 [TBL] [Abstract][Full Text] [Related]
20. Estimating the prognosis of esophageal squamous cell carcinoma based on The Cancer Genome Atlas (TCGA) of m6A methylation-associated genes. Pu Y; Lu X; Yang X; Yang Y; Wang D; Li M; Guan W; Xu M J Gastrointest Oncol; 2022 Feb; 13(1):1-12. PubMed ID: 35284129 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]